{"filing":{"accession_number":"0001104659-26-067614","cik":"0001649989","ticker":"OTLK","company_name":"Outlook Therapeutics, Inc.","form":"8-K","filing_date":"2026-05-28","report_date":null,"primary_document":"tm2615925d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926067614/tm2615925d1_8k.htm"},"events":[{"id":8376,"run_id":7356,"accession_number":"0001104659-26-067614","anchor_item_number":"8.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"The filing discloses a registered direct offering of 8,539,709 shares of common stock at $0.5855 per share, generating approximately $5.0 million in gross proceeds. Additionally, the Company amended outstanding warrants to reduce the exercise price from a weighted average of $1.78 to $0.5855 per share, affecting 15,488,570 shares. This is a material dilutive equity issuance that would significantly affect shareholder ownership and is disclosed under Item 8.01 as a registered direct offering.","company_name":"Outlook Therapeutics, Inc.","ticker":"OTLK","filing_date":"2026-05-28","form":"8-K","submitted_at":null,"items":[{"id":2243,"accession_number":"0001104659-26-067614","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The filing discloses a registered direct offering of 8,539,709 shares of common stock at $0.5855 per share, generating approximately $5.0 million in gross proceeds. Additionally, the Company amended outstanding warrants to reduce the exercise price from a weighted average of $1.78 to $0.5855 per share, affecting 15,488,570 shares. This is a material dilutive equity issuance that would significantly affect shareholder ownership and is disclosed under Item 8.01 as a registered direct offering.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-29T02:17:12.540316+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2243,"accession_number":"0001104659-26-067614","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The filing discloses a registered direct offering of 8,539,709 shares of common stock at $0.5855 per share, generating approximately $5.0 million in gross proceeds. Additionally, the Company amended outstanding warrants to reduce the exercise price from a weighted average of $1.78 to $0.5855 per share, affecting 15,488,570 shares. This is a material dilutive equity issuance that would significantly affect shareholder ownership and is disclosed under Item 8.01 as a registered direct offering.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-29T02:17:12.540316+00:00","company_name":"Outlook Therapeutics, Inc.","ticker":"OTLK","filing_date":"2026-05-28"}]}